SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors discuss the potential for a breakout above the $5 resistance level and speculate about a possible acquisition, particularly by Sanofi, fueled by connections between the companies.  Bullish sentiment is countered by concerns regarding data integrity and trial design, sparking debate within the investment community. Discussions also involve upcoming catalysts and potential price movements, creating a dynamic conversation around the stock's future.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is surging amid enthusiasm around its Gemini 3 AI model, with investors betting it can reclaim the AI throne. Community members are discussing the stock hitting new all-time highs and debating whether it will surpass other tech giants in market cap. Some are wary of overbought conditions and potential pullbacks, while others see it as undervalued compared to peers.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus is trending as investors discuss the potential impact of the Star 26 Capital acquisition, which aims to create a unified defense powerhouse, and are awaiting news of its finalization. Community members are debating whether the stock is poised for a short squeeze, citing its high short interest, or whether dilution and other risks will continue to weigh on the stock. Bullish investors anticipate significant upside potential, while bears express concerns about the company's financial health.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community discusses potential catalysts like ISO 20022 compliance, upcoming partnerships, and the launch of the Super App. Recent integration with NatPay and mentions in relation to a Bloomberg Galaxy DeFi Index have fueled optimism. Community members are actively debating potential price targets, exchange listings, and the long-term potential of ZBCN within the evolving financial landscape.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending amid discussions around AI infrastructure and custom chip potential, with some highlighting its role in Google's Gemini 3 AI model. Community members are debating the stock's valuation and near-term direction, especially with earnings approaching. Optimistic investors point to strong analyst ratings and potential for significant upside, while others express caution due to broader market volatility.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending following news of a strategic $35 million investment in Performance Drone Works (PDW) to scale combat drone production. Community chatter highlights the potential for increased revenue and expansion in the autonomous defense sector, despite some concerns about dilution and market volatility. Some are interpreting the move as a sign of strong growth potential in the broader drone and security landscape.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPM is trending as community members discuss its relationship with crypto, particularly Bitcoin and Ethereum, and potential conflicts of interest involving short positions against companies like $MSTR. Some are calling for boycotts related to past controversies, while others analyze JPM's investment banking activity and technical indicators for potential price movements. There is also speculation about potential impacts from economic factors such as interest rate cuts.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet's GOOGL is trending as chatter suggests it may be emerging as a preferred AI play, with its Gemini 3 model garnering positive reviews and potentially surpassing competitors. Some investors believe GOOGL has the technology and scale to dominate the AI space, leading to discussions of market cap milestones. The community is also reacting to news of Berkshire Hathaway's increased stake in the company, reinforcing bullish sentiment.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is trending due to strong revenue growth and strategic partnerships, including upcoming Hong Kong listing and collaborations with Uber and Grab. Despite positive news, the stock faces challenges as investors debate its valuation and market positioning relative to competitors like Pony.ai. The community is actively discussing upcoming catalysts like Q3 earnings and potential impacts from broader economic and geopolitical factors.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is trending as community members assess recent price drops in light of upcoming earnings, with some suggesting an earnings leak while others anticipate a potential short squeeze. Bullish investors point to the company's low valuation and potential buybacks, while bearish investors express concern about the broader retail environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Strategic Wealth LLC Invests $445,000 in Hims & Hers Health, Inc. $HIMS

Journey Strategic Wealth LLC bought a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm bought...

Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model

HIMS expands its connected care model with new diagnostics, hormonal health services and at-home testosterone treatments.

Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment

Healthcare Stocks Worth Watching - November 20th

UnitedHealth Group, Johnson & Johnson, Hims & Hers Health, Intuitive Surgical, Tempus AI, Medtronic, and GE HealthCare Technologies are the seven Healthcare stocks to watch today, according to...

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL vs. HIMS: Which Stock Is the Better Value Option?

Hims & Hers Health (NYSE:HIMS) CFO Oluyemi Okupe Sells 23,187 Shares

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 23,187 shares of the firm's stock in a transaction dated Monday, November 17th. The stock was sold at an average price of...

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?

Hims & Hers Health may only generate a fraction of its competitors revenue, but its fiscal management and exponential growth point to a very bright future...

Healthcare Stocks To Follow Today - November 19th

UnitedHealth Group, Johnson & Johnson, Medtronic, Intuitive Surgical, Hims & Hers Health, Cardinal Health, and HCA Healthcare are the seven Healthcare stocks to watch today, according to MarketBeat's...

Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?

HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.

Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

$LLY

$NVO

$VKTX

$HIMS

Which weight-loss stock are you most bullish on for the next 5 years?

Current Price	$36.91
Prev Close	$34.71
Open	$35.17
Dividend Yield	0.00%
50-Day Moving Average	$49.10
Beta	2.06
Avg. Volume	28.29M
PE Ratio	64.17

52-Week High	$72.98
52-Week Low	$23.97
Market Capitalization	$7.9B
EPS (Annual)	$0.5322
Price to Book	13.59
Revenue Per Employee	$901,963.35
Enterprise Value/EBITDA	N/A

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HIMS News

HIMSHims & Hers Health Inc